El Nasasra A - Search Results

1

Current clinical management of acute myocardial infarction complicated by cardiogenic shock.

El Nasasra A, Zeymer U. El Nasasra A, et al. Expert Rev Cardiovasc Ther. 2021 Jan;19(1):41-46. doi: 10.1080/14779072.2021.1854733. Epub 2021 Jan 19. Expert Rev Cardiovasc Ther. 2021. PMID: 33289436 Review.

2

Outcomes After Left Main Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock (from the German ALKK PCI Registry).

El Nasasra A, Hochadel M, Zahn R, Schneider A, Thiele H, Darius H, Behrens S, Schumacher B, Ince H, Zeymer U; ALKK-Study Group. El Nasasra A, et al. Am J Cardiol. 2023 Jun 15;197:77-83. doi: 10.1016/j.amjcard.2023.04.007. Epub 2023 May 10. Am J Cardiol. 2023. PMID: 37173201

3

Comparison of Outcomes with or without Beta-Blocker Therapy After Acute Myocardial Infarction in Patients Without Heart Failure or Left Ventricular Systolic Dysfunction (from the Acute Coronary Syndromes Israeli Survey [ACSIS]).

El Nasasra A, Beigel R, Klempfner R, Alnsasra H, Matetzky S, Iakobishvili Z, Rubinshtein R, Halabi M, Blatt A, Zahger D. El Nasasra A, et al. Am J Cardiol. 2021 Mar 15;143:1-6. doi: 10.1016/j.amjcard.2020.12.044. Epub 2021 Jan 12. Am J Cardiol. 2021. PMID: 33359228

4

Ethnic Diversity and Increasing Resistance Patterns of Hospitalized Community-Acquired Urinary Tract Infections in Southern Israel: A Prospective Study.

Elnasasra A, Alnsasra H, Smolyakov R, Riesenberg K, Nesher L. Elnasasra A, et al. Isr Med Assoc J. 2017 Sep;19(9):538-542. Isr Med Assoc J. 2017. PMID: 28971635 Free article.

5

Feasibility and safety of exclusive echocardiography-guided intravenous temporary pacemaker implantation.

El Nasasra A, Alnsasra H, Zahger D, Lerman TT, Kobal S, Cafri C, Haim M, Fuchs L, Shimony A. El Nasasra A, et al. J Echocardiogr. 2019 Sep;17(3):157-161. doi: 10.1007/s12574-018-0406-4. Epub 2018 Nov 13. J Echocardiogr. 2019. PMID: 30426465

6

Aspirin with Low-Dose Ticagrelor or with Low-Dose Rivaroxaban for Secondary Prevention: A Cost per Outcome Analysis.

Tsaban G, Alnsasra H, El Nasasra A, Abu-Salman A, Abu-Dogosh A, Weissberg I, Golan YB, Barrett O, Westreich R, Aboalhasan E, Azuri J, Hammerman A, Arbel R. Tsaban G, et al. Among authors: el nasasra a. Am J Cardiovasc Drugs. 2022 Nov;22(6):677-683. doi: 10.1007/s40256-022-00543-8. Epub 2022 Jul 23. Am J Cardiovasc Drugs. 2022. PMID: 35869410

7

Comparison of Transcatheter Aortic Valve Implantation Devices in Aortic Stenosis: A Network Meta-Analysis of 42,105 Patients.

Dogosh AA, Adawi A, El Nasasra A, Cafri C, Barrett O, Tsaban G, Barashi R, Koifman E. Dogosh AA, et al. Among authors: el nasasra a. J Clin Med. 2022 Sep 8;11(18):5299. doi: 10.3390/jcm11185299. J Clin Med. 2022. PMID: 36142947 Free PMC article.

8

Predictors of Adverse Outcome in High-Risk Percutaneous Coronary Interventions Patients.

Peles I, Barrett O, Cafri C, Garcia-Garcia H, Tsaban G, El-Nasasra A, Abramowitz Y, Shmueli H, Rosenstein G, Merkin M, Zahger D, Koifman E. Peles I, et al. Among authors: el nasasra a. Can J Cardiol. 2023 Oct;39(10):1369-1379. doi: 10.1016/j.cjca.2023.04.021. Epub 2023 Apr 29. Can J Cardiol. 2023. PMID: 37127066

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8 results

Search Page